Aims Among patients with substance dependence and comorbid major depressive disorder
(MDD) receiving treatment in a controlled trial, we examined if group differences in …

Objective: In a population of veterans with co-occurring substance use disorders and
concomitant major depressive disorder, the current study compared mechanisms of change …

Among substance-dependent individuals, comorbid major depressive disorder (MDD) is
associated with greater severity and poorer treatment outcomes, but little research has …

In a randomized trial, this study compared the longitudinal outcome patterns of veterans (N=
66) with substance use disorders and major depressive disorder receiving standard …

The authors compared longitudinal treatment outcomes for depressed substance-dependent
veterans (N= 206) assigned to integrated cognitive–behavioral therapy plus standard …

Interventions for alcohol-and substance-dependent adults with comorbid depressive
disorders are needed, but few have been empirically tested. In a randomized clinical trial of …

Background: We previously published findings from our clinical trial comparing treatment
outcomes for substance-dependent veterans with co-occurring depression who received …

Low attendance in addiction treatment, particularly in cases of comorbidity, has been
identified as a pervasive challenge. We examine predictors of treatment retention in a …

This study grouped treatment-seeking individuals (n= 1825) by common patterns of 12-step
attendance using 5 waves of data (75% interviewed Year 9) to isolate unique characteristics …

Objective: The primary aim of this study was to advance understanding of the efficacy of 12-
step programs by determining the temporal relationships between alcohol and illicit drug …